NeoGenomics, Inc. Operating Lease Right-of-Use Assets
NeoGenomics, Inc. (NEO) had Operating Lease Right-of-Use Assets of $78.61 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-28
- 2026-06-30: Operating Lease, Right-of-Use Asset $78.61M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $76.70M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $78.44M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $80.15M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $78.61M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $76.70M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $78.44M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $80.15M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $82.87M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $77.80M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $79.58M 10-K · filed 2026-02-17 |
| 2024-09-30 | $81.44M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $83.67M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $86.58M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $91.77M 10-K · filed 2025-02-18 |
| 2023-09-30 | $87.13M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $91.41M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $93.78M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $96.11M 10-K · filed 2024-02-20 |
| 2022-09-30 | $98.94M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $99.92M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $101.95M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $102.20M 10-K · filed 2023-02-24 |
| 2021-09-30 | $102.31M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $54.56M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $50.90M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $45.79M 10-K · filed 2022-02-25 |
| 2020-09-30 | $45.86M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $47.55M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $49.08M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $26.49M 10-K · filed 2021-02-25 |
| 2019-09-30 | $25.80M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $26.06M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $19.73M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $9.70M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |